Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 USD | -0.12% | -0.12% | -19.25% |
17/06 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
17/06 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.25% | 599M | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- ZYME Stock
- News Zymeworks Inc.
- Zymeworks Terminates Research, Development, Commercialization Agreement with Daiichi Sankyo